Practice, Value, and Reflections on China's Medical Insurance Payment Policy for Online Drug Purchases

China Health Insurance ›› 2026, Vol. 0 ›› Issue (7) : 73-81.

China Health Insurance ›› 2026, Vol. 0 ›› Issue (7) : 73-81. DOI: 10.19546/j.issn.1674-3830.2026.7.009
Management Platform

Practice, Value, and Reflections on China's Medical Insurance Payment Policy for Online Drug Purchases

Author information +
History +

Abstract

With the deepening of the Digital China Strategy and the integrated development of “Internet plus medical services”, mobile medical insurance payment has become a key direction in the digital transformation of healthcare security, gradually breaking through the spatial constraints of traditional medical insurance payment and reshaping the medical service payment workflow. On the basis of a systematic review of the policy evolution of medical insurance payment for online drug purchases, this paper provides a comprehensive overview of its payment scope, payment structure, participating entities, main models, and local typical experiences. It then summarizes the achievements, including improved service convenience for insured individuals, transformation of medical insurance governance models, sustainable development of the medical insurance fund, and orderly growth of the pharmaceutical industry. The study suggests that online medical insurance payment for drug purchases is currently at a critical juncture, transitioning from local pilot to standardized operation, and from fragmented application to systematic implementation. Accordingly, this paper proposes policy recommendations including accelerating top-level design, strengthening technical support and security safeguards, optimizing promotion and operational mechanisms, and enhancing risk control and comprehensive governance.

Key words

mobile medical insurance payment / online medication purchase / medical insurance services

Cite this article

Download Citations
Practice, Value, and Reflections on China's Medical Insurance Payment Policy for Online Drug Purchases[J]. China Health Insurance. 2026, 0(7): 73-81 https://doi.org/10.19546/j.issn.1674-3830.2026.7.009

References

[1] 刘雨鑫,刘智勇,张研,等.互联网诊疗演进趋势——转型驱动与发展路径研究[J].中国公共卫生,2025,41(10):1274-1280.
[2] 郭阳,刘华子.互联网+医药:医药B2C蓄势待发[J].互联网经济,2016(3):66-73.
[3] 邹萃. 医保服务的互联网革命[J].中国社会保障,2015(12):70-72.
[4] 邵蓉,王梦媛,颜建周,等.我国网售处方药报销面临的问题及对策分析——基于美国药品福利管理模式[J].中国卫生政策研究,2016,9(4):31-36.
[5] 丁腊春,郑湘,朱月兰.互联网支付平台下医保移动支付研究与实践[J].医学信息学杂志,2017,38(8):19-22.
[6] 崔文彬,张焜琨,顾松涛,等.“互联网+”医疗服务纳入医保支付范围研究[J].中国医院,2020,24(3):4-6.
[7] 雷清强,陈天池,廖博玮,等.定点零售药店纳入医保门诊统筹管理实践比较分析[J].中国卫生政策研究,2023,16(12):26-32.
[8] 何慧丽. 医保支付接入医药电商平台:现状审视,挑战分析及对策建议[J].电子商务评论,2024,13:1792.
[9] 唐伟杰. “互联网+”药品采购背景下电商平台的供应链重构与营销转型研究[J].电子商务评论,2025,14:2340.
[10] 葛意,王晓兰,韩俊萍,等.基于前置审方系统的互联网医院处方——外配处方合理用药及医保基金管控体系构建与应用[J].中国药房,2026,37(5):584-588.
[11] 刘琳. 敏捷治理视角下的药品网络交易治理模式探析[J].中国药房,2022,32(20):2433-2437.
[12] 徐关兴,俞亚东,黄卓毅.移动支付与服务模式在宁波智慧医保中的创新应用[J].中国医疗保险,2018(6):31-35.
[13] 俞垠含,朱媛嫄,叶雅琴,等.医保数字化转型探究——以浙江省智慧医保为例[J].统计学与应用,2024,13(2):549-561.
[14] 冉玉焰,邬卫东,田佳琪.基于SWOT分析的医药电商行业发展路径研究[J].电子商务评论,2025,14:1606.
[15] 吴培,董晨东,茅宁莹.“互联网+”背景下处方外流推进障碍与对策分析——基于利益相关者视角[J].中国药房,2022,32(12):1409-1415.
[16] 康蕊,王震.“互联网+”医疗服务医保基金监管的风险与对策[J].中国医疗保险,2021(4):48.
[17] 赵琳琳. 医学电子商务平台的发展现状与未来趋势分析[J].电子商务评论,2026,15:374.
[18] 关月月,黄哲.考虑医保支付政策的药品零售双渠道定价策略研究[J].中国药房,2022,32(16):1926-1932.
[19] 索丽,詹长春.网络购药公众感知效能研究[J].南京医科大学学报(社会科学版),2024,24(6):598-603
[20] 经阳阳. 医疗电商对老年慢性病管理的赋能作用研究[J].电子商务评论,2025,14(9):1436-1442.
[21] 黄国武,仇雨临.医疗保险治理现代化:内在逻辑和路径推演[J].四川大学学报(哲学社会科学版),2019,2:94-102.
[22] 何雪松,罗力.互联网医疗的应用现状和发展趋势[J].中国卫生政策研究,2018,11(9):71-75.
[23] 江积海,刘芮,王烽权.互联网医疗商业模式价值动因的组态效应如何促进价值创造[J].南开管理评论,2022,25(3).
[24] 孔祥溢,王任直.“互联网+医疗”重构中国医疗生态圈的现状与思考[J].医学信息学杂志,2016,37(3):46-52.
[25] 夏杰长,王鹏飞.数字经济赋能公共服务高质量发展的作用机制与重点方向[J].江西社会科学,2021,41(10):38-47.
[26] 宋娟,仇雨临.数字治理推动医保经办增能:应用逻辑与实现路径[J].中国卫生政策研究,2021,14(9):20-24.
[27] 王震.“互联网+”医疗服务纳入医保监管体系的建议[J].中国卫生信息管理杂志,2021,18(5):589-592+619.
[28] 吕晓晨,邓勇.我国网上药店医保支付存在的障碍及其对策探讨[J].中国药房,2016,27(4):573-576.
[29] 康蕊,王震.“互联网+”医疗服务医保基金监管的风险与对策[J].中国医疗保险,2021(4):48.

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉